Biosimilars: What Every Pharmacist Needs to Know

A 2-hour continuing education program for pharmacists and pharmacy technicians

Available until March 4, 2019

Full accreditation information and disclosures are available at: http://elearning.pharmacist.com/products/4534/biosimilars-what-every-pharmacist-needs-to-know

 

Description

How do biologics and biosimilars compare in terms of safety and efficacy? In this session, national experts will discuss the differences between these complex products. Biologics are among the most powerful therapies in use today for patients with cancer, rheumatoid arthritis, multiple sclerosis, and other medical conditions. Biosimilars are biologic agents that are designed to mimic the properties of branded biologics (known as reference products). This session will focus on the status of biosimilars and recent approvals by the U.S. Food and Drug Administration (FDA).

 

Pharmacist Learning Objectives

After completing this activity, the pharmacist will be able to:

  1. Describe the current status of biosimilars in the United States, including recent FDA activity.
  2. Identify potential implications of biosimilars for pharmacists working in various practice settings, including issues of product substitution and interchangeability.
  3. Discuss issues related to efficacy of biosimilars and safety for patients using these agents.
  4. Discuss strategies for determination of appropriate formulary placement of biosimilars.

 

Pharmacy Technician Learning Objectives

After participating in this activity, the technician willl be able to:

  1. Describe the current status of biosimilars in the United States, including recent FDA activity.
  2. Identify potential implications of biosimilars for pharmacists working in various practice settings, including issues of product substitution and interchangeability.
  3. Discuss issues related to efficacy of biosimilars and safety for patients using these agents.
  4. Discuss strategies for determination of appropriate formulary placement of biosimilars.